Patient Guide: A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 114 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06846671
Status: 🟢 Enrolling Now
Condition: CLL, Chronic Lymphocytic Leukemia
Phase: PHASE3

Where You Can Participate

This study is available at 114 locations across the country.

Top locations include:
  • • Whittier, Alaska
  • • Jonesboro, Arkansas
  • • Aurora, Colorado
  • • And 111 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors - Join Clinical Trial NCTNCT06846671

How to Join This Clinical Trial - NCTNCT06846671

Learn how to participate in this PHASE3 trial studying an investigational therapy for CLL, Chronic Lymphocytic Leukemia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with CLL, Chronic Lymphocytic Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
CLL, Chronic Lymphocytic Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06846671 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 114 locations. Find a study site near you:

Clinical Research Site

Whittier, Alaska 90602 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Jonesboro, Arkansas 72401 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Aurora, Colorado 80012-5405 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Fort Myers, Florida 33912 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Weston, Florida 33331-3609 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Atlanta, Georgia 30322-1013 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Baton Rouge, Louisiana 70808-4365 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Bethesda, Maryland 20817-7847 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49503-2560 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Springfield, Missouri 65807-5288 - United States

Status: NOT_YET_RECRUITING

And 104 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for CLL, Chronic Lymphocytic Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships